|
1.Chen, Y. J. et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer science 99, 1507-1514 (2008).
2.Fang, K. H. et al. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer. The Laryngoscope 124, E354-360 (2014).
3.Jones, J.W. et al. The ethics of surgical practice : cases, dilemmas, and resolutions (Oxford ; New York: Ox ford University Press) (2008).
4.Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004).
5.Houston, G. D. Oral pathology. Journal - Oklahoma Dental Association 103, 46-47 (2012).
6.Wei, H., Peng, W., Mao, Y., Liu, B. & Li, S. [Studies on chemical constituents in the fruit of Canarium album Raeusch]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 24, 421-423 (1999).
7.He, Z. Y. et al. Nutritional composition of the kernels from Canarium album L. Food Chemistry 102, 808–811 (2007).
8.He Z. Y. et al. Isolation and structure elucidation of phenolic compounds in Chinese olive (Canarium album L.) fruit. Eur Food Res Technol 226, 1191–1196 (2008).
9.He Z. Y. et al. Analysis of phenolic compounds in Chinese olive (Canarium album L.) fruit by RPHPLC–DAD–ESI–MS. Food Chemistry 105, 1307–1311 (2007).
10.Yen, G. C., Duh, P. D., Tsai, H. L. Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem 79, 307–313 (2002).
11.Yanez, J. et al. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutrition and cancer 49, 191-199 (2004).
12.Liu, Z., Li, D., Yu, L. & Niu, F. Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells. Chemotherapy 58, 185-194 (2012).
13.Nithitanakool, S., Pithayanukul, P. & Bavovada, R. Antioxidant and hepatoprotective activities of thai mango seed kernel extract. Planta medica 75, 1118-1123 (2009).
14.Gorzalczany, S., Lopez, P., Acevedo, C. & Ferraro, G. Anti-inflammatory effect of Lithrea molleoides extracts and isolated active compounds. Journal of ethnopharmacology 133, 994-998 (2011).
15.Esmat, A. et al. Anti-inflammatory activity of Pistacia khinjuk in different experimental models: isolation and characterization of its flavonoids and galloylated sugars. Journal of medicinal food 15, 278-287 (2012).
16.Ito, M. et al. Hepatoprotective compounds from Canarium album and Euphorbia nematocypha. Chemical & pharmaceutical bulletin 38, 2201-2203 (1990).
17.Rosillo, M. A. et al. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacological research : the official journal of the Italian Pharmacological Society 66, 235-242 (2012).
18.Tabara, H., Grishok, A. & Mello, C. C. RNAi in C. elegans: soaking in the genome sequence. Science (New York, N.Y.) 282, 430-431 (1998).
19.Matsui, H., Hikichi, Y., Tsuji, I., Yamada, T. & Shintani, Y. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. The Journal of biological chemistry 277, 50054-50061 (2002).
20.Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature reviews. Cancer 2, 563-572 (2002).
21.Howard, A. & Pelc, S. R. Synthesis of nucleoprotein in bean root cells. Nature 167, 599-600 (1951).
22.Shah, M. A. & Schwartz, G. K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 7, 2168-2181 (2001).
23.Norbury, C. & Nurse, P. Animal cell cycles and their control. Annual review of biochemistry 61, 441-470 (1992).
24.Collins, I. & Garrett, M. D. Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Current opinion in pharmacology 5 (2005).
25.Pardee, A. B. A restriction point for control of normal animal cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 71, 1286-1290 (1974).
26.Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nature reviews. Molecular cell biology 7, 131-142 (2006).
27.Jechlinger, M., Grunert, S. & Beug, H. Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. Journal of mammary gland biology and neoplasia 7, 415-432 (2002).
28.Xue, C., Plieth, D., Venkov, C., Xu, C. & Neilson, E. G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer research 63, 3386-3394 (2003).
29.Wittekind, C. & Neid, M. Cancer invasion and metastasis. Oncology 69 Suppl 1, 14-16 (2005).
30.Thompson, E. W., Newgreen, D. F. & Tarin, D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer research 65, 5991-5995; discussion 5995 (2005).
31.Morgan, H. & Hill, P. A. Human breast cancer cell-mediated bone
collagen degradation requires plasminogen activation and matrix
metalloproteinase activity. Cancer cell international 5, 1 (2005).
32.Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nature reviews. Cancer 3, 768-780 (2003).
|